MEDIKAMENTENABGABESYSTEM

European patent · EP3484543 · In force

Register entry

Publication number
EP3484543
Application number
EP17742974
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 12, 2017
Published
May 22, 2019
Granted
May 21, 2025
Protection ends at the latest
Jul 11, 2037
Next annual fee due
Jul 31, 2027
IPC classes
A61M 5/142 (2006.01)
A61M 5/145 (2006.01)
A61M 5/32 (2006.01)
Priority
EP 16305916 14.07.2016
PCT application
PCT/EP2017/067513 12.07.2017
PCT publication
WO2018/011258 18.01.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Apr 2, 2026

    Change

    Published in Swissreg on 02.04.2026

  3. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  4. May 21, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.05.2025

Parties

Holder

SANOFI

Sanofi

54, rue La Boétie, 75008 Paris, FR

Inventor

FRANKE, Beate

65926 Frankfurt am Main, DE

FORYS, Bernhard

65926 Frankfurt am Main, DE

VERLAAK, Stefan

23877 Paderno d'Adda (LC), IT

MELZI, Ilario

20063 Milano (MI), IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.